Skip to content

Zymeworks ZYME Increase (decrease) in contract liabilities and current deferred income

Increase (decrease) in contract liabilities and current deferred income at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
$5.2M+528%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
-$749K

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.76B+125%
Enterprise value$1.53B+112%
P/S21.6×+13.2×

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's increase (decrease) in contract liabilities and current deferred income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's increase (decrease) in contract liabilities and current deferred income?
Zymeworks (ZYME) reported increase (decrease) in contract liabilities and current deferred income of -$340K in Q1 2026.
How has Zymeworks's increase (decrease) in contract liabilities and current deferred income changed year-over-year?
Zymeworks's increase (decrease) in contract liabilities and current deferred income increased by 83.8% year-over-year, from -$2.09M to -$340K.
What does increase (decrease) in contract liabilities and current deferred income mean?
Represents the net change in deferred revenue arising from payments received from customers before the related performance obligations are satisfied. This is a key indicator of future revenue visibility and the pace of project execution in long-term contracts.